Search

everythinglearnresearchcommunity

for

Search:↓

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Combination therapies might work better for some vitiligo patients, but results vary.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.